A new oral therapy, Zarnestra, has shown benefit in improving blood counts and preventing leukemia development in patients with myelodysplastic syndrome (MDS). The drug, a farnesyl transferase inhibitor, produces responses in about one-third of patients, offering hope for those at high-risk for developing acute myelogenous leukemia (AML).
Researchers found significant variations in GCSE exam entries between schools, driven by subject departments' performance and social background of peers, rather than school type or socio-economic status.
The Global Technology Confidence Index post-election survey found that US tech firms are optimistic about the re-election of President Bush, with over half believing it will benefit their industry. The report also revealed mixed views on business and technology confidence, with some regions experiencing a sharp decline in optimism.